0. Alkali Metals Limited
Presentation

1. About AML
The Company’s strategic focus is to innovate, collaborate and accelerate the process of delivering products to the market for its customers. Today, it is well recognized as a ‘Partner of Choice’ by leading global pharma and Life Sciences companies. The Company through its presence in India, USA, Canada, Europe and Japan constantly serves its customers spread across 10 countries.
AML manufactures variety of products ranging from Alkali Metal Derivatives, Amino Pyridines, Tetrazoles, Cyclic compounds and Fine chemicals. Ours is an ISO 9001 and certified company following GMP Standards. it is constantly engaged in delivering value to its global customers through innovative technologies, products and services.
AML has a dedicated R & D facility recognized by the Ministry of Science and Technology, Govt of INDIA, New Delhi. This facility operates through three modules, being, a laboratory for gram level operation and research, a pilot plant and a proving facility to upscale the production process from pilot plant to a commercial scale and full fledged production.
AML will provide Custom Research And Manufacturing Services (CRAMS) for large, mid-sized and emerging Fine chemicals and pharmaceutical entities globally. This division will deliver fully-consolidated or customized manufacturing solutions for advanced intermediate chemicals of APIs, fine chemicals.

2. HISTORY
Established in 1968
Sodium Alkoxide s
Diversified into Sodium Derivatives.
R&D development of New Products based on Sodium and Pyridines & Derivatives
Started amino pyridines, Cyclic compounds, Fine Chemicals & Tetrazoles
Started Commercial production at Unit-III, Vizag
Engaged in manufacturin g of Alkali Metals and produced Sodium Metal
Sodium Amide
Sodium Azide
Sodium Hydride
Successfully completed IPO and listed in NSE & BSE API plant under implementation
Commercialization of 2,3-DCP

3. PROMOTERS Sri Y.S.R. Venkata Rao
Alkali Metals Ltd (AML) was established in April by late Dr. Y.V.S.S. Murty, who was the founder Chairman to manufacture Sodium Metal and down stream chemicals in its plants at Hyderabad,India.
Mr. Y. S. R. Venkata Rao, who is the Current Managing Director of Alkali Metals Ltd. is a technocrat and second generation entrepreneur. He is a Mechanical Engineer and Fellow of the Institution of Engineers (India).
He is Associated with the Company from 1977 and  has been playing a pivotal role in steering the growth of  the Company to a leading manufacturer of alkali metals, and its derivatives, amino pyridines, cyclic compounds, fine chemicals, which find wide application in various industries like Pharma and Agro chemicals sectors . 
Dr. Y.V.S.S. Murty
Sri Y.S.R. Venkata Rao

4. Alkali Metals Limited - Hyderabad, India
Sales : 640 million INR
Assets : 613 million INR
Employees : 300 members
Main Business:
Manufacture of sodium derivatives, pyridine derivatives, fine chemicals and Contract Research and Manufacturing Services (CRAMS)

5. OUR STRENGTHS Significant expertise in Alkali Metal Derivatives
Largest manufacturer of Sodium Azides, Amides, Hydride with unique Technology
Strong Chemical Engineering Skills
Expertise in handling Hazardous Chemicals
Leading manufacturer of Pyridine Derivatives
All products are completely based on In-house Technology and Engineering.
Port folio of 341 products
Off shoring capabilities
Focus on high margin Custom Synthesis & Contract Manufacturing
Full fledged R&D facilities for product and process development
Consistent profit generating business operations

6. Chemistry Capabilities
Expertise in manufacture of products of involving Hazardous Chemistry
Asymmetric Synthesis
Reductions, Oxidations (Catalytic, Chemical) and Epoxidation
Julia Olefination, Wittig and Wittig-Horner reaction
Organo metallic (Grignard, Blaise, Reformatsky,etc) Reactions
Halogenations, Chlorosulphonation
Resolution & Racemisation
Alkylation & Amidation
Cyanation Reactions
Rearrangement Reactions
High pressure, autoclave / hydrogenation reactions even at higher temperatures up to 250° C
Small scale (milligram) to bigger scale (2 kilos) can be handled in the laboratory
Dedicated pilot plant facility for further scale up
Equipped to handle reagents like n-butyl lithium, boron trifluoride, DIBAL, sodium azide, etc.

7. Expertise in manufacture of products of involving Hazardous Chemistry
Reaction
Lab
Pilot
Commercial
Alkylation
Yes
Metal Alcoxides
Bromination
Mannich Reaction No
Balz - Schiemam reaction (- NH2 to - F)
Nitration
Boronic acids (with BuLi / Grignard)
N -Oxidations
Birch reduction
Reductive amination (-CHO to -CH2NH2)
Chichibabin Reaction
Chlorination
a) -Cl to -OR
Condensation Reactions
b) -Cl to -F

8. Expertise in manufacture of products of involving Hazardous Chemistry
Curtius rearrangement
Yes No
Reduction
Cyclisation
a) -NO2 to - NH2
Cyanation (- Br to -CN)
b) -CN to CH2NH2
Diazotisation
c) Pyridyl to Piperidyl
Esterification
Sandmeyer Reaction
Friedel - Craft Reaction
Tetrazole
Fluorination
Wittig Reaction
Hoffman rearrangement
Wolf-kishner reduction
Metal Hydrides

9. OUR EXPERTISE

10. ALKALI METAL DERIVATIVES SODIUM AMIDE
KEY PRODUCTS
PRODUCT SEGMENT
PRODUCTS
APPLICATIONS
ALKALI METAL DERIVATIVES
SODIUM AMIDE
PHARMA INTERMEDIATES (SELECT THERAPIES)
ANTI RETROVIRALS
FLU VACCINE (TAMIFLU)
ANTIBIOTICS (CIPRO)
AGROCHEMICALS
SODIUM AZIDE
SODIUM HYDRIDE
(60% OIL SUSPENSION)
SODIUM TERTIARY BUTOXIDE
SODIUM METHOXIDE
(POWDER / SOLUTION)
SODIUM ETHOXIDE
(POWDER / SOLUTION)
HEXAMETHYL DISILAZANE
SODIUM SALT
POTASSIUM METAL DERIVATIVES
(POTASSIUM METHOXIDE SOLN. &
POTASSIUM TERT. BUTOXIDE)

11. 5-METHYL- 1Ht-1,2,3,4-TETRAZOLE 5 AMINO 1H-1,2,3,4-TETRAZOLE
KEY PRODUCTS
PRODUCT SEGMENT
PRODUCTS
APPLICATIONS
TETRAZOLES
1H-1,2,3,4-TETRAZOLE
5-METHYL- 1Ht-1,2,3,4-TETRAZOLE
5 AMINO 1H-1,2,3,4-TETRAZOLE
(MONOHYDRATE / ANHYDROUS)
5-(4-METHYL PHENYL)- 1H-1,2,3,4-TETRAZOLE
PHARMA INTERMEDIATES
AGROCHEMICALS
AUTOMOBILE
PYRIDINE DERIVATIVES
2-AMINO PYRIDINE
PHARMA INTERMEDIATES
CARDIO / ANTI INFLAMMATION
AGRO CHEMICALS
2-AMINO - 4/5/6 - METHYL PYRIDINE
2, 6-DIAMINO PYRIDINE

12. FINE CHEMICALS / DRUG DISCOVERY CHEMICALS CYCLO PENTANONE
KEY PRODUCTS
PRODUCT SEGMENT
PRODUCTS
APPLICATIONS
FINE CHEMICALS / DRUG DISCOVERY CHEMICALS
CYCLO PENTANONE
CYCLO PENTANOL
CYCLO PENTYL MANDELIC ACID
CYCLO HEXYL MANDELIC ACID
PHENYL PYRIDYL ACETONITRILE PHENYL PYRIDYL ACETAMIDE
BROMO ACETALDEHYDE DIMETHYL ACETAL
TRI PHENYLPHOSPHINE TRIMETHYL BORATE
PHARMA INDUSTRY
PHARMA PRODUCTS & INTERMEDIATES
SULPHA PYRIDINE
DISOPYRAMIDE
PHENAZO PYRIDINE HCL
METHYL PHENIDATE HCL
PHARMA & FORMULATION

13. Geographical Break-up of Sales
CURRENT FINANCIALS
Geographical Break-up of Sales FY FY FY
Japan 7%
Japan
Belgium
India 8% 5%
66%
Italy
Italy
10%
25%
Belgium
India 5%
Others
51%
Germany
12%
Others 5% 6%
687 million INR
685 million INR
650 million INR FY FY FY
666 million INR 13

14. Profit and Loss Account - Last 7 Years
(Rupees in Millions)
Particulars   
Income
Gross Sales of products manufactured by the company
649.35
687.04
685.38
604.09
691.47
632.57
666.05
Less: Excise Duty & Sales Tax
49.25
69.36
47.56
31.93
35.45
40.03
46.84
Net Sales of products manufacturing by the company
600.10
617.68
637.82
572.16
656.02
592.54
619.21
Other Income
1.21
0.42
2.05
3.78
1.30
18.44
7.94
Increase / (Decrease) in Stock
38.69
35.25
(38.38)
(1.06)
16.29
(115.65)
18.86
Total
640.00
653.35
601.49
574.88
673.61
495.33
646.01
Expenditure
Raw materials Consumed
353.26
361.66
280.82
240.73
305.80
277.39
311.86
Employees cost
42.55
50.51
52.27
48.75
  67.58
72.43
68.02
Power & Fuel
59.25
62.06
65.96
67.87
92.75
93.36
98.83
Other Manufacturing Cost
15.47
16.93
35.27
63.88
59.09
64.21
65.07
Research & Development Expenses
19.28
10.77
13.54
9.63
31.29
20.16
16.27
Marketing Expenses
28.49
25.71
23.67
22.33
36.34
28.94
23.90
Interest ( Financial Expenses)
20.29
17.72
12.75
7.05
24.92
38.55
31.16
Depreciation
16.87
18.17
18.50
19.17
26.12
31.26
34.81
555.46
563.53
502.78
479.41
643.89
626.30
649.92
Net profit before extra ordinary Items & Tax
84.55
89.82
98.71
95.47
29.72
(130.97)
3.91

15. Particulars   
Extra Ordinary Items:  
Loss on Sale of Investment
0.00
Short / (Excess) provision for previous years
4.04
(-)19.74
8.25
0.34
Current tax (Provision and payment)
6.00
10.50
11.20
16.30
6.40
Deferred Tax
2.50
(0.25)
9.72
11.87
24.23
(43.98)
Net profit after Tax
76.05
79.32
87.76
65.41
31.19
(163.46)
47.55
Amount available for appropriation
APPROPRIATION
Provision for Dividend
27.15
27.75
40.73
20.37
10.18
Provision For tax on Dividend
3.81
4.72
6.92
3.32
1.65
Transfer to General Reserve
8.00
10.00
2.97
Balance Carried over to Balance Sheet
37.09
38.85
30.11
7.76
4.53
(11.83)
35.72

16. SUMMARY OF ASSETS AND LIABILITIES – Last 7 Years
Particulars   
DETAILS
Fixed Assets
Gross Block (Including Capital WIP)
383.01
418.46
539.76
628.45
743.64
812.67
834.98
LESS: Depreciation
83.42
101.49
119.73
138.88
164.46
195.43
230.08
Net Block(A)
299.59
316.97
420.03
489.57
   
617.24
604.90
Investments (B)
0.00
91.88
16.88
Current Assets, Loans &Advances
Inventories
124.01
130.93
108.59
110.21
255.74
125.12
145.06
Sundry Debtors
82.10
121.00
143.99
132.57
112.42
113.53
137.23
Cash and Bank Balances
1.30
0.41
13.75
48.67
17.72
10.11
12.18
Loans and Advances
54.33
95.56
78.56
126.07
174.80
205.39
104.43
Sub Total (C )
261.74
347.95
344.89
417.52
560.68
454.15
398.90
PRELIMINARY & PRE-OPERATIVE EXPENDITURE(D)
9.01
33.00
26.40
 19.80
13.20
6.60
Loans and Liabilities
Secured Loans
203.16
237.37
110.03
185.76
351.32
194.34
218.76
Deferred Sales Tax Liability
14.63
18.10
19.01
21.26
23.90
26.98
Current Liabilities and Provisions
39.07
67.14
106.93
141.65
105.64
319.08
225.65
Sub Total (E)
256.87
322.61
235.97
346.42
478.22
537.32
471.39
Deferred Tax (F)
10.50
10.26
19.97
31.84
56.08
12.10
Net Worth (A+B+C+D-E-F)
293.96
340.82
643.59
658.98
666.48
491.19
526.91

17. Particulars   
Represented by
Share Capital
60.34
69.39
101.83
Reserves & Surplus
233.62
271.43
541.76
557.15
564.65
389.36
425.08
Less: Miscellaneous Expenditure
Net Worth
293.96
340.82
643.59
658.98
666.48
491.19
526.91

18. Export Customers
Products exported to leading companies in Japan, Europe, South America and USA.
Mitsubishi Corporation
Innochem (Belgium)
DKSH (formerly Siber Hegner) (Japan)
Mitsui & Co Ltd (Japan)
Archmica (Italy)
Polydene (Italy)
TEVA (Israel)
Saltigo
and many others

19. Domestic Customers Dr Reddy’s Laboratories Ranbaxy Laboratories
Mylan Laboratories
Aurobindo Pharma
Hetero Drugs
Unimark
Sanofi Aventis
Lupin Laboratories
Glenmark Life Sciences
and many others

20. MANUFACTURING FACILITIES
In 3 different locations, 2 locations within 8 to 34 kms from the city of Hyderabad
and 3rd one at JN Pharma city, Visakhapatnam, India
27 acres of land with a built up area of 24,000 sq m and
a total workforce (engineers, scientists, technicians and workmen) of 300
UNIT I : Plot No. B-5, Block-III, IDA Uppal, Hyderabad – ,
Contact No: , Mobile No:
Production of sodium derivatives, tetrazoles, amino pyridines, Cyclic compounds and fine chemicals
Manufacturing for domestic market
UNIT II : Survey No 299, 300 & 301, Dommara Pochampally(V), Qutubullapur (M), PIN – , R.R.Dist, India.
ID : ; Mobile No:
Production of sodium derivatives, alkoxides and amino pyridines,
Manufactinring for domestic and export oriented unit
UNIT III : Plot No. 38, J.N.Pharma City,Parawada, Visakhapatnam – ID :
mobile No:
Production of Intermediates and APIs.
Land Area : 65,000 Sq.Mt.,
Plant in compliant with cGMP to meet US FDA norms.
Strong Process and Chemistry Skills
ISO 9001 certification / ISO certification
Adept in manufacturing Sodium / pyridine derivatives
Ability to expand further (Growth potential of 12% – 15% in sales)

21. MANUFACTURING FACILITIES
UNIT I
UNIT II
UNIT III
Land Sq. m
21,000
22,000
65,000
Built Up Area Sq. m
7,100
5,300
8,000
Total Floor Area Sq. m
13,000
7,000
12,000
Water Source Cu.m/day
150
150
350
Water Storage Cu.m
300
200
600
Power KVA
750
725
1500
Standby power KVA
900
900
1800
Hot Oil System K. cal
2 M Kcal/Hr.
1 M Kcal/Hr.
3 M Kcal/Hr.
300 TR
300 TR
500 TR
Steam Kg/hr Pressure
Cooling Water
1T, 7 kgs/cm2
3T, 7 kgs/cm2
3T, 7 kgs/cm2
Refrigeration -10º C
80 T.R.
40 T.R
100 T.R
Refrigeration -40º C
2 T.R. --
4 T.R.
500 Cu.m
600 Cu.m
1000 Cu.m
Bulk liquid storage 1
200 Cu.m
150 Cu.m
300 Cu.m
Plant Reactors2
14 Cu.m
4 Cu.m
15 Cu.m
R&D Reactors3
75 Cu.m/hr
50 Cu.m/hr
100 Cu.m/hr
Inert gas
Distillation Columns nos. 4 3 5
Mixers/Blenders (MS,SS) nos. 14 2 15
Dryers nos. 4 2 5
Centrifuges nos. 12 2 12
Incinerator nos. 1 1 2
1 For solvents, fuel oils & other consumable, 2 (CS., SS 304, GLR, Copper, Lead Lined) Pressure (0.001 Hg-5 Kg, 25 Kg/cm sq)
3 (Glass, MS, SS, GLR, Copper, Lead Lined) Pressure (0.001 Hg-5 Kg, 25 Kg, 50 Kg, 100 Kg/cm.sq)

22. Unit wise capacities and utilization
Unit-I
Unit-II
Unit-III
Capabilities
Dedicated R & D
Sodium derivatives
Pyridine derivatives and fine chemicals
Capacity
Up to pilot plant level
3250 MT/year
60 M3 SS and 20 M3 GLR
Capacity utilization
50%
90%
Available capacity
10%

23. MANUFACTURING FACILITIES UNIT-I - B-5, Block-III, IDA, Uppal, Hyderabad.

24. MANUFACTURING FACILITIES UNIT-I - B-5, Block-III, IDA, Uppal, Hyderabad.

25. MANUFACTURING FACILITIES UNIT-I - B-5, Block-III, IDA, Uppal, Hyderabad.

26. Analytical Facility

27. MANUFACTURING FACILITIES UNIT-II -- D.P. Pally Village, R.R. District

28. MANUFACTURING FACILITIES UNIT-II -- D.P. Pally Village, R.R. District

29. MANUFACTURING FACILITIES UNIT-II -- D.P. Pally Village, R.R. District

30. MANUFACTURING FACILITIES UNIT-II -- D.P. Pally Village, R.R. District

31. MANUFACTURING FACILITIES UNIT-III -- JNPC, VISAKHAPATNAM

32. MANUFACTURING FACILITIES UNIT-III -- JNPC, VISAKHAPATNAM

33. MANUFACTURING FACILITIES UNIT-III -- JNPC, VISAKHAPATNAM

34. RESEARCH & DEVELOPMENT FACILITIES
All products are completely based on in-house technology and engineering
R & D
MODULE I
MODULE II
Laboratory for gram level operation and research
Pilot plant for 1 – 10 kg production
MODULE III
Proving facility to upscale from pilot plant to commercial scale and establish full fledged production

35. RESEARCH & DEVELOPMENT FACILITIES

36. Board of Directors NAME Position DR. J.S. YADAV Chairman
MANAGEMENT
Board of Directors
NAME
Position
DR. J.S. YADAV Chairman
MR. CH.S. PRASAD Independent Director
MR. P.C. PATNAIK Independent Director
MR. G. JAYARAMAN Independent Director
MR. Y.S.R. VENKATA RAO Managing Director
MS. Y. LALITHYA POORNA Director

37. ORGANISATION STRUCTURE
Board of Directors
YSR Venkata Rao
Managing Director
Company Secretary /
Chief Financial Officer
Chief Operational Officer
Chief Executive Officer
General Manager /
Dy. General Manager
General Manager /
Dy. General Manager
General Manager /
Dy. General Manager
Purchases &
Stores
Sales &
Distribution
HR&
Administration
Secretarial Dept
Finance & Accounts Depts.
Marketing
Quality Management Systems (QMS)
Environmental Management Systems (EMS)
Production &
Maintenance
Safety
Research &
Development

38. In-House R&D Centre recognized by
CERTIFICATIONS
In-House R&D Centre recognized by
Ministry of Science & Technology, Govt. of India
R&D Centre
“Export House” recognition from
Director General of Foreign Trade, Govt. of India
Export House
Quality Management System (QMS) certified by
Bureau Veritas Certification since 1995
ISO 9001:2008
Environmental Management System (EMS)
certified by Bureau Veritas Certification
Since 2000
ISO 14000
REACH
Pre registration obtained for 8 products
DMF # 19595
DMF for Sodium Azide

39. GLOBAL EXPOSURE
Countries of Exports
Alkali Metals Ltd.

40. Regular participant in international exhibitions like
GLOBAL EXPOSURE
Regular participant in international exhibitions like
CPhI, Chemspec, Informex, PhiUS. 40

41. “Best technology development in research & development”
AWARDS
“Best technology development in research & development”
“Best Export Performance Award”
“Outstanding performance in the field of Technology”
“Certificate of Merit for the outstanding export performance”

42. Lifetime Achievement Honour”
AWARDS
Lifetime Achievement Honour” 42

43. To penetrate further into the Global Market
FORWARD LOOKING
To penetrate further into the Global Market
Further diversification into various segments such as
Pharmaceutical & Agro Industries
Work in progress for developing R&D products in the segments of Anti-Cancer, Anti-Viral Studies.
More focused on CRAMS

44. Expertise in manufacture of products involving hazardous chemistry
SUMMARY
A leading manufacturer of sodium derivatives, pyridine derivatives and fine chemicals
Portfolio of 341 products
Expertise in manufacture of products involving hazardous chemistry
Strategic tie-up with IICT, Hyderabad for R &D
Directors with decades of experience in industry and R & D
Dedicated and loyal staff
Looked at by customers not only as a supplier but also a strategic partner for reliable and quality products
Full fledge testing facilities with modern testing facilities

45. Thank You